Non-linear interactions between candidate genes of myocardial infarction revealed in mRNA expression profiles

Katherine Hartmann1,2, Michał Seweryn3,4, Samuel K Handelman5,6

  • 1College of Medicine Center for Pharmacogenomics, The Ohio State University Wexner Medical Center, Biomedical Research Tower, 460 W 12th Avenue, Columbus, OH, USA. katherine.hartmann@osumc.edu.

BMC Genomics
|September 19, 2016
PubMed
Abstract

Insights

Investigating non-linear gene interactions reveals critical molecular networks for myocardial infarction (MI) risk. This study identifies novel gene pairs and pathways, improving understanding of complex disease and biomarker development.

Area of Science:

  • Genomics
  • Systems Biology
  • Bioinformatics

Background:

  • Gene expression alterations are crucial in disease development.
  • Individual genes may be insufficient for complex diseases like myocardial infarction (MI).
  • Molecular network dysregulation is critical for pathogenic processes, often involving non-linear interactions.

Purpose of the Study:

  • To investigate non-linear interactions in mRNA expression profiles for MI risk.
  • To identify significant gene-gene interactions using logistic regression and expression data.
  • To build and expand molecular networks for MI pathophysiology.

Main Methods:

  • Logistic regression analysis of individual candidate genes and non-linear interaction terms.
  • Utilized microarray data from CATHGEN and FHS, and RNAseq data from GTEx.
  • Identified co-expressed RNA pairs and additional linking RNAs to expand interaction networks.

Main Results:

  • Identified significant non-linear interaction terms for individual genes and mRNA pairs among 41 MI candidate genes.
  • Two gene pairs (CNNM2|GUCY1A3 and CNNM2|ZEB2) replicated across CATHGEN and FHS datasets.
  • Discovered extended pathways, such as CNNM2|ACSL5|SCARF1|GUCY1A3, highlighting magnesium and lipid processing roles.

Conclusions:

  • Non-linear gene interactions play a significant role in MI.
  • Sparse gene networks can be expanded using co-expression analysis for comprehensive insights.
  • Findings offer a new strategy for developing clinical biomarker panels for MI.